Bridge Biotherapeutics Presented Non-clinical Study Results for 2 IPF Candidates at the IPF Summit 2022 ...Middle East

Non-clinical studies explored the potent anti-fibrotic and anti-inflammatory efficacy of BBT-301 and BBT-209 for IPF treatment Company enhances its strategic focus on fibrotic diseases inclusive of IPF with 1 clinical asset and 2 non-clinical assets BOSTON and SEONGNAM, South Korea, Sept....

Read More Details
Finally We wish PressBee provided you with enough information of ( Bridge Biotherapeutics Presented Non-clinical Study Results for 2 IPF Candidates at the IPF Summit 2022 )

Also on site :

• Trump Steps Out for Rare Date Night With Melania Amid ICE Protests
• Country Icon Is Nearly Unrecognizable Returning From Years-Long Hiatus
• US preparing to partially evacuate Iraq embassy over regional security risks, sources say